| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R1
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Strategies to Protect the Health of Deployed U.S. Forces
Detecting, Characterizing, and Documenting Exposures
Thomas E. McKone, Beverly M. Huey, Edward Downing, and Laura M. Duffy, Editors
Strategies to Protect the Health of Deployed U.S. Forces: Technology and Methods for Detection and Tracking of Exposures to a Subset of Harmful Agents
Division of Military Science and Technology
Commission on Engineering and Technical Systems
Board on Environmental Studies and Toxicology
Commission on Life Sciences
National Research Council
NATIONAL ACADEMY PRESS
WASHINGTON, D.C.
OCR for page R2
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The author responsible for the report was chosen for his special competencies.
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Bruce Alberts is president of the National Academy of Sciences.
This is a report of a study supported by Contract DASW01-97-C-0078 between the Department of Defense and the National Academy of Sciences. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for the project.
International Standard Book Number 0-309-06875-4
Limited copies are available from:
Board on Army Science and Technology
National Research Council
2101 Constitution Avenue, N.W.
Washington, DC 20418
(202) 334-3118
Additional copies are available for sale from:
National Academy Press
Box 285 2101 Constitution Ave., N.W. Washington, DC 20055 (800) 624-6242 (202) 334-3313 (in the Washington Metropolitan Area) http://www.nas.edu
Copyright 2000 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America.
OCR for page R3
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
THE NATIONAL ACADEMIES
National Academy of Sciences
National Academy of Engineering
Institute of Medicine
National Research Council
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Bruce M. Alberts is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. William A. Wulf is president of the National Academy of Engineering.
The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute of Medicine.
The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy's purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Bruce M. Alberts and Dr. William A. Wulf are chairman and vice chairman, respectively, of the National Research Council.
OCR for page R4
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
STRATEGIES TO PROTECT THE HEALTH OF DEPLOYED U.S. FORCES
Technology and Methods for Detection and Tracking of Exposures to a Subset of Harmful Agents
Principal Investigator
THOMAS E. MCKONE,
University of California, Berkeley, and Lawrence Berkeley National Laboratory, Berkeley, California
Advisory Panel
WYETT H. COLCLASURE II,
Environmental Technologies Group, Inc., Jarrettsville, Maryland
MARGARET L. JENKINS,
California Air Resources Board, Sacramento, California
TREVOR O. JONES,
BIOMEC, Inc., Cleveland, Ohio
MICHAEL LEBOWITZ,
University of Arizona College of Medicine, Tucson
KEITH MCDONALD,
Sat Tech Systems, Inc., Alexandria, Virginia
ROBERT SHOPE,
University of Texas Medical Branch, Galveston
ROBERT SPEAR,
University of California, Berkeley
PAUL SWITZER,
Stanford University, Stanford, California
DETLOF VON WINTERFELDT,
Decision Insights, Inc., Irvine, California
CHARLES J. WESCHLER,
Telcordia Technologies, Red Bank, New Jersey
Board on Army Science and Technology Liaisons
CLARENCE G. THORNTON,
Army Research Laboratories (retired), Colts Neck, New Jersey
JOSEPH J. VERVIER,
ENSCO, Inc., Melbourne, Florida
Department of Defense Liaisons
MICHAEL KILPATRICK,
Office of the Special Assistant for Gulf War Illnesses, Falls Church, Virginia
FRANCIS O'DONNELL,
Office of the Special Assistant for Gulf War Illnesses, Falls Church, Virginia
OCR for page R5
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Staff
BRUCE A. BRAUN, Director,
Division of Military Science and Technology
JAMES REISA, Director,
Board on Environmental Studies and Toxicology
BEVERLY M. HUEY, Study Director
RAY WASSEL, Senior Program Officer
EDWARD J. DOWNING, Senior Program Officer
LAURA M. DUFFY, Research Associate
NORMAN M. HALLER, Technical Consultant
PAMELA A. LEWIS, Senior Project Assistant
ANDRE MORROW, Senior Project Assistant
OCR for page R6
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
BOARD ON ARMY SCIENCE AND TECHNOLOGY
WILLIAM H. FORSTER, chair,
Northrop Grumman Corporation, Baltimore, Maryland
THOMAS L. MCNAUGHER, vice chair,
RAND Corporation, Washington, D.C.
ELIOT A. COHEN,
School of Advanced International Studies, Johns Hopkins University, Washington, D.C.
RICHARD A. CONWAY,
Union Carbide Corporation (retired), Charleston, West Virginia
GILBERT F. DECKER,
Walt Disney Imagineering, Glendale, California
PATRICK F. FLYNN,
Cummins Engine Company, Inc., Columbus, Indiana
EDWARD J. HAUG,
NADS and Simulation Center, The University of Iowa, Iowa City, Iowa
ROBERT J. HEASTON,
Guidance and Control Information Analysis Center (retired), Naperville, Illinois
ELVIN R. HEIBERG, III,
Heiberg Associates, Inc., Mason Neck, Virginia
GERALD J. IAFRATE,
University of Notre Dame, Notre Dame, Indiana
DONALD R. KEITH,
Cypress International, Alexandria, Virginia
KATHRYN V. LOGAN,
Georgia Institute of Technology, Atlanta, Georgia
JOHN E. MILLER,
Oracle Corporation, Reston, Virginia
JOHN H. MOXLEY,
Korn/Ferry International, Los Angeles, California
STEWART D. PERSONICK,
Drexel University, Philadelphia, Pennsylvania
MILLARD F. ROSE,
NASA Marshall Space Flight Center, Huntsville, Alabama
GEORGE T. SINGLEY, III,
Hicks and Associates, Inc., McLean, Virginia
CLARENCE G. THORNTON,
Army Research Laboratories (retired), Colts Neck, New Jersey
JOHN D. VENABLES,
Venables and Associates, Towson, Maryland
JOSEPH J. VERVIER,
ENSCO, Inc., Melbourne, Florida
ALLEN C. WARD,
Ward Synthesis, Inc., Ann Arbor, Michigan
Staff
BRUCE A. BRAUN, Director
MICHAEL A. CLARKE, Associate Director
MARGO L. FRANCESCO, Staff Associate
CHRIS JONES, Financial Associate
DEANNA SPARGER, Senior Project Assistant
OCR for page R7
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
COMMISSION ON ENGINEERING AND TECHNICAL SYSTEMS
W. DALE COMPTON, chair,
Purdue University, West Lafayette, Indiana
ELEANOR BAUM,
Cooper Union for the Advancement of Science and Art, New York, New York
RUTH M. DAVIS,
Pymatuning Group, Inc., Alexandria, Virginia
HENRY J. HATCH,
American Society of Civil Engineers, Reston, Virginia
STUART L. KNOOP,
Oudens and Knoop, Architects, PC, Chevy Chase, Maryland
NANCY G. LEVESON,
Massachusetts Institute of Technology, Cambridge
CORA B. MARRETT,
University of Massachusetts, Amherst
ROBERT M. NEREM,
Georgia Institute of Technology, Atlanta
LAWRENCE T. PAPAY,
SAIC, San Diego, California
BRADFORD W. PARKINSON,
Stanford University, Stanford, California
JERRY SCHUBEL,
New England Aquarium, Boston, Massachusetts
BARRY M. TROST,
Stanford University, Stanford, California
JAMES C. WILLIAMS,
GE Aircraft Engines, Cincinnati, Ohio
RONALD W. YATES,
U.S. Air Force (retired), Monument, Colorado
Staff
DOUGLAS BAUER, Executive Director
DENNIS CHAMOT, Deputy Executive Director
CAROL R. ARENBERG, Technical Editor
OCR for page R8
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
BOARD ON ENVIRONMENTAL STUDIES AND TOXICOLOGY
GORDON ORIANS, chair,
University of Washington, Seattle
DONALD MATTISON, vice chair,
March of Dimes, White Plains, New York
DAVID ALLEN,
University of Texas, Austin
INGRID C. BURKE,
Colorado State University, Fort Collins
WILLIAM L. CHAMEIDES,
Georgia Institute of Technology, Atlanta
JOHN DOULL,
University of Kansas Medical Center, Kansas City
CHRISTOPHER B. FIELD,
Carnegie Institute of Washington, Stanford, California
JOHN GERHART,
University of California, Berkeley
J. PAUL GILMAN,
Celera Genomics, Rockville, Maryland
BRUCE D. HAMMOCK,
University of California, Davis
MARK HARWELL,
University of Miami, Miami, Florida
ROGENE HENDERSON,
Lovelace Respiratory Research Institute, Albuquerque, New Mexico
CAROL HENRY,
Chemical Manufacturers Association, Arlington, Virginia
BARBARA HULKA,
University of North Carolina, Chapel Hill
JAMES F. KITCHELL,
University of Wisconsin, Madison
DANIEL KREWSKI,
University of Ottawa, Ottawa, Ontario
JAMES A. MACMAHON,
Utah State University, Logan
MARIO J. MOLINA,
Massachusetts Institute of Technology, Cambridge
CHARLES O'MELIA,
Johns Hopkins University, Baltimore, Maryland
WILLEM F. PASSCHIER,
Health Council of the Netherlands, The Hague
KIRK SMITH,
University of California, Berkeley
MARGARET STRAND,
Oppenheimer, Wolff, Donnelly & Bayh, LLP, Washington, D.C.
TERRY F. YOSIE,
Chemical Manufacturers Association, Arlington, Virginia
Staff
JAMES J. REISA, Executive Director
DAVID J. POLICANSKY, Associate Director
OCR for page R9
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
COMMISSION ON LIFE SCIENCES
MICHAEL T. CLEGG, chair,
University of California, Riverside
PAUL BERG, vice chair,
Stanford University, Stanford, California
FREDERICK R. ANDERSON,
Cadwalader, Wickersham and Taft, Washington, D.C.
JOHN C. BAILAR, III,
University of Chicago, Chicago, Illinois
JOANNA BURGER,
Rutgers University, Piscataway, New Jersey
SHARON L. DUNWOODY,
University of Wisconsin, Madison
DAVID EISENBERG,
University of California, Los Angeles
JOHN EMMERSON,
Consultant, Portland, Oregon
NEAL FIRST,
University of Wisconsin, Madison
DAVID J. GALAS,
Chiroscience R&D, Inc., Bothell, Washington
DAVID V. GOEDDEL,
Tularik, Inc., South San Francisco, California
ARTURO GOMEZ-POMPA,
University of California, Riverside
COREY S. GOODMAN,
University of California, Berkeley
HENRY HEIKKINEN,
University of Northern Colorado, Greeley
BARBARA S. HULKA,
University of North Carolina, Chapel Hill
HANS J. KENDE,
Michigan State University, East Lansing
CYNTHIA KENYON,
University of California, San Francisco
MARGARET G. KIDWELL,
University of Arizona, Tucson
BRUCE R. LEVIN,
Emory University, Atlanta, Georgia
OLGA F. LINARES,
Smithsonian Tropical Research Institute, Miami, Florida
DAVID LIVINGSTON,
Dana-Farber Cancer Institute, Boston, Massachusetts
DONALD R. MATTISON,
March of Dimes, White Plains, New York
ELLIOT M. MEYEROWITZ,
California Institute of Technology, Pasadena
ROBERT T. PAINE,
University of Washington, Seattle
RONALD R. SEDEROFF,
North Carolina State University, Raleigh
ROBERT R. SOKAL,
State University of New York, Stony Brook
CHARLES F. STEVENS,
Salk Institute, La Jolla, California
SHIRLEY M. TILGHMAN,
Princeton University, Princeton, New Jersey
JOHN L. VANDERBERG,
Southwest Foundation for Biomedical Research, San Antonio, Texas
RAYMOND L. WHITE,
University of Utah, Salt Lake City
Staff
WARREN R. MUIR, Executive Director
OCR for page R10
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
This page in the original is blank.
OCR for page R11
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Preface
Since Operation Desert Shield/Desert Storm, Gulf War veterans have expressed concerns about health effects that could be associated with their deployment and service during the war. Although similar concerns were raised after other military operations, the Gulf War deployment focused national attention on the potential, but uncertain, relationship between the presence of chemical and biological (CB) agents and other harmful agents in theater and health symptoms reported by military personnel.
A number of studies have addressed the issues of veterans' health and the potential health effects of their service, focused mostly on understanding the current health of veterans, ensuring that they are receiving appropriate evaluation and care, and determining the connections between veterans' current health status and service in, and specific exposures during, the Gulf War. As a result of these studies, the U.S. Department of Defense (DoD) has begun to focus more on better monitoring and control of exposures to multiple harmful agents.
Responding to this need, the DoD Office of the Special Assistant for Gulf War Illnesses, through the National Academies, sponsored Strategies to Protect the Health of Deployed U.S. Forces, a study that consists of four two-year studies followed by a consensus study. At the end of the second year (November 1999), the four study groups are issuing reports to DoD and the public on their findings and recommendations. These reports will then be used as a basis for a consensus study by a new National Academies committee in the third year of the project. The consensus committee's report will include the issues raised in the four
OCR for page R20
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Proximate Sampling
34
Personal Sampling
34
Biological Markers
35
Modeling, Simulations, and Decision Analyses
36
Exposure Modeling
36
Models of Daily Intake
38
Simulations
38
Needs, Capabilities, and Opportunities
39
Tracking Strategies and Emerging Needs
39
Real-Time Monitoring Strategies
39
Prospective Monitoring Strategies
40
Retrospective Monitoring Strategies
42
Data Storage, Management, and Analyses
42
Use of Scenarios, Training, and Exercises
42
Making Exposure Assessment Operational
42
Findings and Recommendations
43
TECHNICAL ANNEX
46
Components of An Exposure Assessment
46
Dimensions of Harm
48
3
THRESHOLDS OF HEALTH EFFECTS FOR CHEMICAL AND BIOLOGICAL AGENTS
50
Chemical Agents
51
Chemical Warfare Agents
53
Toxic Industrial Chemicals
53
Biological Agents
56
Biological Warfare Agents
56
Endemic Biological Organisms
57
Relationship between Exposure and Toxicity for Chemical and Biological Agents
57
Findings and Recommendations
65
4
ENVIRONMENTAL AND EXPOSURE PATHWAYS
68
Environmental Transport, Environmental Pathways, and Exposure Routes
68
Defining and Ranking Required Information
70
Sources and Emissions
72
Environmental Transport and Transformation
73
Exposure Routes
78
Exposure Scenarios and Environmental Pathways
79
Potential Exposures, Classified by Time Scale and Plausibility
80
Past and Present Threats
80
OCR for page R21
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Agents of Concern During the Persian Gulf War
81
Future Threats
83
Ranking Potential Exposures Based on Dimensions of Harm
83
Multiple (Concurrent/Sequential) Exposures
84
Findings and Recommendations
85
5
DETECTING AND MONITORING HARMFUL AGENTS
86
Detecting and Monitoring Chemical Agents
87
Measuring Chemical Concentrations
89
Sampling
90
Separating and Detecting Chemical Agents
92
Aerosol-Phase Detection
95
Current Methods
95
Detecting Chemicals in Water, Food, and Soil
97
Summary Evaluation of Chemical Detection Technologies
98
Detecting and Monitoring Biological Agents
99
Measuring Biological Organisms
99
Emerging and Traditional Detection Technologies
102
Emerging Technologies
103
Fielded Equipment for Biological Agents
104
Emerging Equipment
105
Data Collection, Recording, and Storage
105
Multipurpose Integrated Chemical Alarm
106
Joint Warning and Reporting Network (JWARN)
106
System Goals
107
Monitoring, Simulation, and Decision Making
107
Testing Equipment and Field Demonstration
108
Findings and Recommendations
108
6
TRACKING THE LOCATIONS AND TIME-ACTIVITY BUDGETS OF DEPLOYED MILITARY PERSONNEL
110
Activity Pattern Data
110
Methods of Obtaining Time-Activity Data
111
Global Positioning System
112
Activity Diaries and Logs
113
Questionnaires
118
Videotaping
119
Observers
119
Other Methods of Tracking Activities
119
Factors That Determine Human Activities and Locations
120
Evaluation of Current and Emerging Tracking Methods
120
OCR for page R22
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Preventing Acute Exposures
121
Estimating Long-Term Exposures
122
Findings and Recommendations
123
7
STRATEGY CONSIDERATIONS
125
Recommended Adjustments in Strategy
126
Technical Aspects
127
Recommendations
127
Defining Needs
127
Determining Exposure
128
Handling Data
128
Doctrine, Training, and Administration
129
REFERENCES
130
APPENDICES
A Defining the Decision Framework and the Value of Exposure Information in Military Deployments
147
B Harmful Properties of Chemical Agents
161
C Harmful Properties of Biological Agents
184
D Detecting and Monitoring Chemical Agents
191
E Detecting and Monitoring Biological Agents
212
F Contributors to This Study
225
G Biographical Sketches of Principal Investigator and Members of the Advisory Panel
230
H Meetings and Activities
235
OCR for page R23
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Box, Tables, and Figures
BOX
4-1
U.S. Demolition Operations at the Khamisiyah Ammunition Storage Point
75
TABLES
2-1
Questions To Be Answered by a CB Training Exercise
43
3-1
Exposure Factors for Selected Biological Warfare Agents
58
3-2
Characteristics of Selected Biological Toxins
60
4-1
Potential Exposures of Deployed Personnel
82
5-1
Information Needs and Timing for Measuring Short-Term Threats and Long-Term Health Risks
88
5-2
Criteria for Selecting Analytical Methods for Detecting Biological Contaminants
100
6-1
Time Spent in Major Locations by U.S. Adults over 17 Years of Age
111
6-2
Expected Evolution of GPS Performance
114
B-1
Lethal Chemical Warfare Agents
162
B-2
Debilitating and Incapacitating Chemical Warfare Agents
164
B-3
Chemical Categories of Toxic Industrial Chemicals
173
C-1
Exposure Factors for Selected Biological Warfare Agents
186
C-2
Characteristics of Selected Biological Toxins
188
OCR for page R24
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
D-1
Estimates of Chemical Agent Exposure Limits
193
D-2
Sensitivity of Chemical Agent Detection and Monitoring Equipment
194
FIGURES
2-1
Links between concentration data and time-activity data
47
2-2
The dimensions-of-harm scale
49
3-1
Variations in the median lethal air exposure, LCt50, and median incapacitating air exposure, ICt50, for some chemical warfare agents
62
3-2
The EC50 (the 30-minute average air concentration that would result in the LCT50) compared to the estimated safe dose and the Surgeon General's AELs
62
3-3
Estimated safe air concentrations for some TICs regulated by the EPA and some chemical agents
63
3-4
Estimated safe water concentrations for some TICs regulated by EPA
64
4-1
Links among environmental media, exposure media, and exposure routes
69
5-1
The three steps for measuring chemical concentrations in an environmental medium (air, water, soil, or food)
89
5-2
Detection sensitivities for detection equipment compared to the EC50 (the 30-minute average air concentration that would result in the LCT50), DoD's estimated safe concentration, and the AEL
98
A-1
A taxonomy of information needs
151
A-2
Influence diagram showing the relationships and effects of uncertainty on exposure information, health effects, and decisions
151
A-3
Decision tree for using protective clothing
152
A-4
Analyzed decision tree for using protective clothing
153
A-5
Decision tree with perfect information
153
A-6
Analyzed decision tree with perfect information
154
A-7
Decision tree with imperfect information
155
A-8
Decision tree with imperfect information (simplified)
156
A-9
Analyzed decision tree with imperfect information (simplified)
157
A-10
Decision tree illustrating the value of new information
158
OCR for page R25
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Abbreviations and Acronyms
AC
hydrogen cyanide (blood chemical agent)
AEL
allowable exposure limit
ATOFMS
aerosol time-of-flight mass spectrometry
B(a)P
benzo(a)pyrene
CARC
chemical-agent resistant coatings
CATI
computer-assisted telephone interview system
CB
chemical and/or biological
CDC
Centers for Disease Control and Prevention
CEHR
Center for Environmental Health Research
CG
phosgene (chemical choking agent)
CHPPM
Center for Health Promotion and Preventive Medicine
COT
Committee on Toxicology
CX
phosgene oxime (urticant chemical agent)
DEHP
di-2-ethylhexylphthalate
DNA
deoxyribonucleic acid
DoD
U.S. Department of Defense
OCR for page R26
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
EC50
the airborne concentration of a chemical agent sufficient to produce severe effects in 50 percent of those exposed for 30 minutes
ED50
the amount of liquid agent on the skin sufficient to produce severe effects in 50 percent of the exposed population
ELISA
enzyme-linked immunoassay
PA
Environmental Protection Agency
FTIR
Fourier transform infrared
GA
tabun
GAO
General Accounting Office
GB
sarin
GD
soman
GPS
global positioning system
H
Levinstein mustard
HAP
hazardous air pollutant
HCB
hexachlorobenzene
HCH
hexachlorocyclohexane
HD
distilled mustard
HEPA
high-efficiency particulate air filters
HL
mustard-lewisite mixture
HN
nitrogen mustard
HVAC
heating, ventilation, and air-conditioning
H2S
hydrogen sulfide
ICt50
the incapacitating effect of a vapor or aerosol agent, which is the product of the concentration and exposure time, sufficient to disable 50 percent of a group of exposed and unprotected personnel at an assumed breathing rate (active or resting)
ID50
the dose in mg or mg/kg of liquid agent expected to incapacitate 50 percent of a group of exposed unprotected personnel
IDLH
immediately dangerous to life and health
IMS
ion mobility spectrometry
IPT
Integrated Product Team
JCS
joint Chiefs of Staff
JSMG
Joint Service Materiel Group
JWARN
Joint Warning and Reporting Network
OCR for page R27
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
L
lewisite
LCt50
a measure of vapor or aerosol agent lethality, which is the product of the concentration and exposure time that is lethal to 50 percent of a group of exposed and unprotected personnel at an assumed breathing rate (active or resting)
LD50
a measure of liquid agent lethality; the dose in milligrams (kg) of liquid agent or mg of agent delivered per kilogram (kg) of body weight expected to kill 50 percent of a group of exposed, unprotected personnel
MICAD
multipurpose integrated chemical agent alarm
MIST
Man-in-Simulant Test Program
NBC
nuclear, biological, chemical
NHEXAS
National Human Exposure Assessment Studies
NOx
nitrogen oxides
NRC
National Research Council
OSHA
Occupational Safety and Health Administration
PAH
polycyclic aromatic hydrocarbon
PCB
polychlorinated biphenyls
PCD
phosphorous chemiluminescence detector
PCE
Tetrachloroethylene
PCR
polymerase chain reaction
PD, ED, MD
double chlorinated arsines
P-DCB
1, 4-dichlorobenzene
PEP
propellants, explosives, and pyrotechnics
PIC
personal information carrier
PIDS
photo-ionization detectors
PIRS
photoacoustic infrared spectroscopy
PVC
polyvinylchloride
R&D
research and development
RfC
chronic reference safe concentration
RfD
chronic reference safe dose
RNA
ribonucleic acid
SAW
surface acoustic wave
SBCCOM
Soldier and Biological Chemical Command
OCR for page R28
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
TEAM
total exposure assessment methodology
TIC
toxic industrial chemicals
TIME
total isolated by microenvironment exposure (monitor)
TCDD
2,3,7,8 tetetrachloro-dibenzo-p-dioxin
TCE
trichloroethylene
TWA
time-weighted average
VX
nerve agent
VX2
binary form of nerve agent VX
Vx
volatile nerve agent similar to VX
VOC
volatile organic compound
VOI
value of information
OCR for page R29
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
Strategies to Protect the Health of Deployed U.S. Forces
OCR for page R30
Strategies to Protect the Health of Deployed U.S. Forces: Detecting, Characterizing, and Documenting Exposures
This page in the original is blank.